• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】41010

【品名】(3S)-3-(2-hydroxyethoxy)-4-(trityloxy)-1-butanol

【CA登记号】

【 分 子 式 】C25H28O4

【 分 子 量 】392.49492

【元素组成】C 76.5% H 7.19% O 16.31%

与该中间体有关的原料药合成路线共 3 条

合成路线1

该中间体在本合成路线中的序号:(IX)

Treatment of (R)-1-chloro-2,3-propanediol (I) with either K2CO3 or Cs2CO3 in CH2Cl2, followed by O-protection with Trt-Cl and Et3N in CH2Cl2, yields (S)-trityl glycidol (II). Alternatively, derivative (II) can also be obtained either by direct O-protection of (R)-glycidol (III) by means of Trt-Cl and Et3N in refluxing CH2Cl2 or by cyclization of protected propanediol derivative (IV)--obtained from treatment of compound (I) with Trt-Cl and Et3N in CH2Cl2--by means of KOH in EtOH. Reaction of (S)-trityl glycidol (II) with vinyl magnesium bromide (V) by means of CuI in THF provides (S)-1-(triphenylmethoxy)-4-penten-2-ol (VI), which is then condensed with allyl bromide (VII) with KOtBu or NaH in THF to afford compound (VIII). Ozonolysis of (VIII) in CH2Cl2/MeOH, followed by reductive quench with NaBH4 in NaOH, gives (S)-3-(2-hydroxyethoxy)-4-(triphenylmethoxy)-1-butanol (IX), which is then treated with MsCl/Et3N in CH2Cl2 to yield bismesylate (X). Coupling of compound (X) with 2,3-bis(1H-indol-3-yl)-N-methylmaleimide (XI) [obtained by treatment of dichloromaleic anhydride (XII) with methylamine hydrochloride by means of NaOMe in HOAc to furnish dichloro-N-methylmaleimide (XIII), followed by Grignard reaction of (XIII) with indole (XIV) in toluene/THF by means of EtMgBr in Et2O] by means of Cs2CO3 in DMF gives the 14-membered macrocycle (XV).

1 Faul, M.M.; Sullivan, K.A.; Neel, D.A.; Krumrich, C.A.; Jirousek, M.R.; Winneroski, L.L.; Gillig, J.R.; Rito, C.J.; Macrocyclic bisindolylmaleimides: Synthesis by inter- and intramolecular alkylation. J Org Chem 1998, 63, 6, 1961.
2 Engel, G.L.; Farid, N.A.; Faul, M.M.; Jirousek, M.R.; Richardson, L.A.; Winneroski, L.L. Jr. (Eli Lilly and Company); Protein kinase C inhibitor. EP 0776895; JP 1999500149; US 5710145; WO 9718809 .
3 Faul, M.M.; Winneroski, L.L. Jr.; Krumrich, C.A. (Eli Lilly and Company); Intermediates and their use to prepare N,N'-bridged bisindolylmaleimides. US 5721272 .
4 Rito, C.J.; Mcdonald, J.H. III; Jirousek, M.R.; Winneroski, L.L. Jr.; Heath, W.F. Jr.; Faul, M.M. (Eli Lilly and Company); Improved synthesis of bisindolylmaleimides. EP 0657411; US 5541347 .
5 Faul, M.M.; Winneroski, L.L. Jr.; Krumrich, C.A. (Eli Lilly and Company); Intermediates and their use to prepare N,N'-bridged bisindolylmaleimides. EP 0776899 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 49696 (S)-(+)-Alpha-Chlorohydrin; (S)-(+)-3-Chloro-1,2-propanediol; (S)-3-Chloro-1,2-propanediol 60827-45-4 C3H7ClO2 详情 详情
(II) 41006 (2S)-oxiranylmethyl trityl ether; (2S)-2-[(trityloxy)methyl]oxirane C22H20O2 详情 详情
(III) 19241 (2S)oxiranylmethanol 60456-23-7 C3H6O2 详情 详情
(IV) 51942 (2R)-1-chloro-3-(trityloxy)-2-propanol C22H21ClO2 详情 详情
(V) 16524 bromo(vinyl)magnesium 1826-67-1 C2H3BrMg 详情 详情
(VI) 41007 (2S)-1-(trityloxy)-4-penten-2-ol C24H24O2 详情 详情
(VII) 11463 3-Bromo-1-propene; 3-Bromopropene;allyl bromide 106-95-6 C3H5Br 详情 详情
(VIII) 41008 1-[[[(2S)-2-(allyloxy)-4-pentenyl]oxy](diphenyl)methyl]benzene; allyl (1S)-1-[(trityloxy)methyl]-3-butenyl ether C27H28O2 详情 详情
(IX) 41010 (3S)-3-(2-hydroxyethoxy)-4-(trityloxy)-1-butanol C25H28O4 详情 详情
(X) 51943 (7S)-2,11-dimethyl-2,11-dimethylene-7-[(trityloxy)methyl]-3,6,10-trioxa-2lambda(6),11lambda(6)-dithia-1,11-dodecadiene; 2-[[methyl(dimethylene)-lambda(6)-sulfanyl]oxy]ethyl (1S)-3-[[methyl(dimethylene)-lambda(6)-sulfanyl]oxy]-1-[(trityloxy)methyl]propyl ether C31H40O4S2 详情 详情
(XI) 51012 5-(tert-butyl) 1-(2,3,5,6-tetrafluorophenyl) (2S)-2-[[(2S)-2-[[(benzyloxy)carbonyl]amino]-5-(tert-butoxy)-5-oxopentanoyl]amino]pentanedioate C32H38F4N2O9 详情 详情
(XII) 21947 3,4-dichloro-2,5-furandione 1122-17-4 C4Cl2O3 详情 详情
(XIII) 41029 3,4-dichloro-1-methyl-1H-pyrrole-2,5-dione C5H3Cl2NO2 详情 详情
(XIV) 15292 Indole; 1H-indole 120-72-9 C8H7N 详情 详情
(XV) 41016 (18S)-4-methyl-18-[(trityloxy)methyl]-17-oxa-4,14,21-triazahexacyclo[19.6.1.1(7,14).0(2,6).0(8,13).0(22,27)]nonacosa-1(28),2(6),7(29),8,10,12,22,24,26-nonaene-3,5-dione C46H39N3O4 详情 详情

合成路线2

该中间体在本合成路线中的序号:(IX)

Protection of (R)-glycidol (I) with trityl chloride (II) and TEA in dichloromethane gives the trityl ether (III), which is condensed with vinylmagnesium bromide (IV) in THF to yield the pentenol (V). The alkylation of (V) with allyl bromide (VI) by means of NaH in THF affords the allyl ether (VII), which is oxidized with O3 in methanol/dichloromethane, giving dialdehyde (VIII). Reduction of (VIII) with NaBH4 in ethanol provides diol (IX), which is treated with mesyl chloride and TEA in dichloromethane to afford the fully protected alcohol (X). Cyclization of (X) with 3,4-bis(3-indolyl)-1-methyl-2,5-dihydro-1H-pyrrole-2,5-dione (XI) by means of Cs2CO3 in DMF yields the hexacyclic compound (XII), which is N-demethylated by reaction with KOH in refluxing ethanol to give the hexacyclic furan derivative (XIII), which is then treated with hexamethyldisilazane (HMDS) in hot methanol to afford the hexacyclic demethylated pyrrole (XIV). Elimination of the trityl protecting group of (XIV) with HCl in dichloromethane gives the methanol derivative (XV), which is treated with Br2, pyridine and triphenyl phosphite in dichloromethane to yield the bromomethyl derivative (XVI). Finally, this compound is treated with dimethylamine in DMF to provide LY-333531. Alternatively, compound (XV) is treated with methanesulfonic anhydride and pyridine in THF, giving the mesylate (XVII), which is then treated with dimethylamine as before.

1 Faul, M.M.; Sullivan, K.A.; Neel, D.A.; Krumrich, C.A.; Jirousek, M.R.; Winneroski, L.L.; Gillig, J.R.; Rito, C.J.; Macrocyclic bisindolylmaleimides: Synthesis by inter- and intramolecular alkylation. J Org Chem 1998, 63, 6, 1961.
2 Sorbera, L.A.; Rabasseda, X.; Silvestre, J.S.; Castañer, J.; LY-333531 Mesylate Hydrate. Drugs Fut 2000, 25, 10, 1017-1026.
3 Engel, G.L.; Farid, N.A.; Faul, M.M.; Jirousek, M.R.; Richardson, L.A.; Winneroski, L.L. Jr. (Eli Lilly and Company); Protein kinase C inhibitor. EP 0776895; JP 1999500149; US 5710145; WO 9718809 .
4 Faul, M.M.; Winneroski, L.L. Jr.; Krumrich, C.A. (Eli Lilly and Company); Intermediates and their use to prepare N,N'-bridged bisindolylmaleimides. US 5721272 .
5 Rito, C.J.; Mcdonald, J.H. III; Jirousek, M.R.; Winneroski, L.L. Jr.; Heath, W.F. Jr.; Faul, M.M. (Eli Lilly and Company); Improved synthesis of bisindolylmaleimides. EP 0657411; US 5541347 .
6 Faul, M.M.; Winneroski, L.L. Jr.; Krumrich, C.A. (Eli Lilly and Company); Intermediates and their use to prepare N,N'-bridged bisindolylmaleimides. EP 0776899 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 16260 (R)-(+)-Glycidol; (2R)-Oxiranemethanol; (2R)oxiranylmethanol 57044-25-4 C3H6O2 详情 详情
(II) 28630 Triphenylchloromethane; 1-[Chloro(diphenyl)methyl]benzene; Trityl chloride 76-83-5 C19H15Cl 详情 详情
(III) 41006 (2S)-oxiranylmethyl trityl ether; (2S)-2-[(trityloxy)methyl]oxirane C22H20O2 详情 详情
(IV) 16524 bromo(vinyl)magnesium 1826-67-1 C2H3BrMg 详情 详情
(V) 41007 (2S)-1-(trityloxy)-4-penten-2-ol C24H24O2 详情 详情
(VI) 11463 3-Bromo-1-propene; 3-Bromopropene;allyl bromide 106-95-6 C3H5Br 详情 详情
(VII) 41008 1-[[[(2S)-2-(allyloxy)-4-pentenyl]oxy](diphenyl)methyl]benzene; allyl (1S)-1-[(trityloxy)methyl]-3-butenyl ether C27H28O2 详情 详情
(VIII) 41009 (3S)-3-(2-oxoethoxy)-4-(trityloxy)butanal C25H24O4 详情 详情
(IX) 41010 (3S)-3-(2-hydroxyethoxy)-4-(trityloxy)-1-butanol C25H28O4 详情 详情
(X) 41011 (3S)-3-[2-[(methylsulfonyl)oxy]ethoxy]-4-(trityloxy)butyl methanesulfonate C27H32O8S2 详情 详情
(XI) 41012 3,4-di(1H-indol-3-yl)-1-methyl-1H-pyrrole-2,5-dione 113963-68-1 C21H15N3O2 详情 详情
(XII) 41016 (18S)-4-methyl-18-[(trityloxy)methyl]-17-oxa-4,14,21-triazahexacyclo[19.6.1.1(7,14).0(2,6).0(8,13).0(22,27)]nonacosa-1(28),2(6),7(29),8,10,12,22,24,26-nonaene-3,5-dione C46H39N3O4 详情 详情
(XIII) 41017 (18S)-18-[(trityloxy)methyl]-4,17-dioxa-14,21-diazahexacyclo[19.6.1.1(7,14).0(2,6).0(8,13).0(22,27)]nonacosa-1(28),2(6),7(29),8,10,12,22,24,26-nonaene-3,5-dione C45H36N2O5 详情 详情
(XIV) 41014 (18S)-18-[(trityloxy)methyl]-17-oxa-4,14,21-triazahexacyclo[19.6.1.1(7,14).0(2,6).0(8,13).0(22,27)]nonacosa-1(28),2(6),7(29),8,10,12,22,24,26-nonaene-3,5-dione C45H37N3O4 详情 详情
(XV) 41013 (18S)-18-(hydroxymethyl)-17-oxa-4,14,21-triazahexacyclo[19.6.1.1(7,14).0(2,6).0(8,13).0(22,27)]nonacosa-1(28),2(6),7(29),8,10,12,22,24,26-nonaene-3,5-dione C26H23N3O4 详情 详情
(XVI) 41018 (18S)-18-(bromomethyl)-17-oxa-4,14,21-triazahexacyclo[19.6.1.1(7,14).0(2,6).0(8,13).0(22,27)]nonacosa-1(28),2(6),7(29),8,10,12,22,24,26-nonaene-3,5-dione C26H22BrN3O3 详情 详情
(XVII) 41015 [(18S)-3,5-dioxo-17-oxa-4,14,21-triazahexacyclo[19.6.1.1(7,14).0(2,6).0(8,13).0(22,27)]nonacosa-1(28),2(6),7(29),8,10,12,22,24,26-nonaen-18-yl]methyl methanesulfonate C27H25N3O6S 详情 详情

合成路线3

该中间体在本合成路线中的序号:(VII)

The intermediate (S)-3-(2-mesyloxyethoxy)-4-(triphenylmethoxy)-1-butanol mesylate (VIII) has been obtained as follows: The hetero Diels Alder cyclization of ethyl glyoxylate (I) with butadiene (II) in toluene at 160-70 C gives racemic 3,6-dihydro-2H pyran-2-carboxylic acid ethyl ester (III), which is submitted to enzymatic resolution by means of B.lentus protease, yielding a mixture of the hydrolyzed (R)-acid and unchanged (S)-ester (IV), that is easily separated. The reduction of the (S)-ester (IV) by means of LiAlH4 in THF affords the hydroxymethyl derivative (V), which is treated with Tr-Cl and DMAP in pyridine to provide the trityl ether (VI). Ozonolysis of the dihydropyran ring of (VI) by means of ozone and NaBH4 in dichloromethane/methanol gives (S)-3-(2-hydroxyethoxy)-4-(triphenylmethoxy)-1-butanol (VII). Finally this compound is treated with Ms-Cl and TEA in dichloromethane to yield the target intermediate (S)-3-(2-mesyloxyethoxy)-4-(triphenylmethoxy)-1-butanol mesylate (VIII). (see scheme no. 25239601a, intermediate no. (X).

1 Caille, J.C.; Hetero diels-alder-biocatalysis approach for the synthesis of (S)-3-[2-{(methylsulfonyl)oxy}ethoxy]-4- (triphenylmethoxy)-1-butanol sulfonate, a key intermediate for the synthesis of the PKC inhibitor LY333531. Org Process Res Dev 2002, 6, 4, 471.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 48591 Ethyl glyoxylate; Ethyl oxoacetate; Glyoxylic acid ethyl ester 924-44-7 C4H6O3 详情 详情
(II) 11579 1,3-Butadiene; Butadiene 106-99-0 C4H6 详情 详情
(III) 56904 ethyl 3,6-dihydro-2H-pyran-2-carboxylate C8H12O3 详情 详情
(IV) 56905 ethyl (2S)-3,6-dihydro-2H-pyran-2-carboxylate C8H12O3 详情 详情
(V) 56906 (2S)-3,6-dihydro-2H-pyran-2-ylmethanol C6H10O2 详情 详情
(VI) 56907 (2S)-2-[(trityloxy)methyl]-3,6-dihydro-2H-pyran; (2S)-3,6-dihydro-2H-pyran-2-ylmethyl trityl ether C25H24O2 详情 详情
(VII) 41010 (3S)-3-(2-hydroxyethoxy)-4-(trityloxy)-1-butanol C25H28O4 详情 详情
(VIII) 41011 (3S)-3-[2-[(methylsulfonyl)oxy]ethoxy]-4-(trityloxy)butyl methanesulfonate C27H32O8S2 详情 详情
Extended Information